Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

NCT03602508 is registered in ClinicalTrials.gov with Astellas Pharma Singapore Pte. Ltd. as lead sponsor.

NCT NCT03602508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03602508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
Lead sponsor
Astellas Pharma Singapore Pte. Ltd.
Phase
Observational
Overall status
Completed
Start date
July 20, 2018
Completion date
September 13, 2019
Enrollment
5,589 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder (oab)